Iceland vs Italy: Breast cancer screening coverage in Europe
Iceland
54.0%
in 2021
Italy
53.5%
in 2022
Iceland rank
13th
Italy rank
14th
Breast cancer screening coverage in Europe over time
- Iceland
- Italy
How they compare
Iceland currently reports 54.0% against 53.5% in Italy, a difference of 0.5%.
The two have swapped places 7 times across 18 shared years of data; in 2004 it was Iceland ahead.
Iceland ranks 13th and Italy ranks 14th of 26 countries.
Across the 3 decades both report, Iceland averaged higher in 2 and Italy in 1.
Head to head by decade
| Decade | Iceland | Italy | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 61.5% | 60.1% | 1.4% | Iceland |
| 2010s | 58.2% | 59.1% | 0.9% | Italy |
| 2020s | 58.0% | 53.5% | 4.5% | Iceland |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher breast cancer screening coverage in europe, Iceland or Italy?
- Iceland, at 54.0% against 53.5% in Italy as of 2021.
- What is the difference in breast cancer screening coverage in europe between Iceland and Italy?
- 0.5%, with Iceland ahead.
- How many years of comparable data are there for Iceland and Italy?
- 18 years are reported by both, from 2004 to 2021.
- How do Iceland and Italy rank globally for breast cancer screening coverage in europe?
- Iceland ranks 13th and Italy ranks 14th of 26 countries.
- Where does this data come from?
- Eurostat (2024) β processed by Our World in Data, published as Breast cancer screening coverage in Europe. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Share of women aged 50 to 69 years who have been screened for breast cancer within the previous 2 years.